To evaluate the safety and tolerability of zavegepant for the acute treatment of migraine in female adults.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: